1. Home
  2. CLNN vs BDL Comparison

CLNN vs BDL Comparison

Compare CLNN & BDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLNN
  • BDL
  • Stock Information
  • Founded
  • CLNN 2012
  • BDL 1959
  • Country
  • CLNN United States
  • BDL United States
  • Employees
  • CLNN N/A
  • BDL N/A
  • Industry
  • CLNN Biotechnology: Pharmaceutical Preparations
  • BDL Restaurants
  • Sector
  • CLNN Health Care
  • BDL Consumer Discretionary
  • Exchange
  • CLNN Nasdaq
  • BDL Nasdaq
  • Market Cap
  • CLNN 60.3M
  • BDL 52.7M
  • IPO Year
  • CLNN N/A
  • BDL N/A
  • Fundamental
  • Price
  • CLNN $8.48
  • BDL $31.84
  • Analyst Decision
  • CLNN Strong Buy
  • BDL
  • Analyst Count
  • CLNN 6
  • BDL 0
  • Target Price
  • CLNN $32.67
  • BDL N/A
  • AVG Volume (30 Days)
  • CLNN 146.3K
  • BDL 2.4K
  • Earning Date
  • CLNN 11-12-2025
  • BDL 08-12-2025
  • Dividend Yield
  • CLNN N/A
  • BDL 1.77%
  • EPS Growth
  • CLNN N/A
  • BDL 41.91
  • EPS
  • CLNN N/A
  • BDL 2.32
  • Revenue
  • CLNN $286,000.00
  • BDL $201,851,000.00
  • Revenue This Year
  • CLNN N/A
  • BDL N/A
  • Revenue Next Year
  • CLNN $1,363.77
  • BDL N/A
  • P/E Ratio
  • CLNN N/A
  • BDL $13.33
  • Revenue Growth
  • CLNN N/A
  • BDL 8.84
  • 52 Week Low
  • CLNN $2.28
  • BDL $22.61
  • 52 Week High
  • CLNN $11.06
  • BDL $35.98
  • Technical
  • Relative Strength Index (RSI)
  • CLNN 54.52
  • BDL 52.24
  • Support Level
  • CLNN $7.66
  • BDL $30.23
  • Resistance Level
  • CLNN $8.58
  • BDL $32.90
  • Average True Range (ATR)
  • CLNN 0.93
  • BDL 1.11
  • MACD
  • CLNN -0.17
  • BDL -0.03
  • Stochastic Oscillator
  • CLNN 26.22
  • BDL 60.51

About CLNN Clene Inc.

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

About BDL Flanigan's Enterprises Inc.

Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.

Share on Social Networks: